Examining the Health and Pregnancy Outcomes for Women Undergoing IVF study

What is the Examining the Health and Pregnancy Outcomes for Women Undergoing IVF study?

Recent research has suggested that new therapies that increase the pregnancy rates for women undergoing IVF are needed. We are currently testing a new therapy which is not currently offered at your IVF Centre. To assist our research we are seeking women to volunteer to take part in our study  and to complete some questionnaires which ask about your well being, coping, the use of health services  and  the outcome of your IVF cycle. Your data will be compared with women using the new treatment being tested to assess if there is any difference between groups.

This is an important study because new therapies are unlikely to be offered to women until we have a better understanding of the advantages or any problems associated with the treatment and its effect on embyro transfer outcomes.

Who can take part?

Women who wish to take part need to meet all the following criteria to take part in the study:

  • Women less than 43 years of age undergoing IVF 
  • Undergoing a fresh IVF or ICSI cycle

Women who wish to take part cannot be:

  • receiving acupuncture (need to stop acupuncture two weeks before starting your IVF cycle)
  • having a frozen cycle
  • previously been in the study
  • planning pre-implantation genetic diagnosis
  • receiving donor eggs. 
Women will be reimbursed $50 for their time.

I'm interested in taking part, what do I have to do?

If you are interested in taking part in this study, please contact the researchers for more information. Researchers can be contacted by email, s.fogarty@uws.edu.au or phone 02 4620 3290.

Thank you for your interest.
This study is being conducted by the Centre for Health Research Complementary Medicine Research at the University of Western Sydney by Associate Professor Caroline Smith, University of Western Sydney, Associate Professor Sheryl de Lacey and Professor Julie Ratcliffe from Flinders University, and Professor Michael Chapman, IVF Australia.